News
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...
Stocks closed higher Tuesday to extend a week-long rally as investors digested a flurry of earnings reports from major ...
At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and ...
Novo Nordisk announced it is partnering with telehealth platforms to offer its blockbuster drug Wegovy. The move will help it ...
Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...
Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular ...
Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant ...
In essence, Hims & Hers is embracing a "if you can't beat 'em, join 'em" approach that gives their customers more options.
Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on ...
A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight-loss drugs Ozempic ...
A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results